Class information for:
Level 1: DRUG INDUCED PARKINSONISM//DOTARIZINE//DOPAMINE RECEPTOR BLOCKING AGENTS

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
23891 331 24.5 60%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
110 3       PSYCHIATRY//SCHIZOPHRENIA//BIPOLAR DISORDER 71389
2247 2             TARDIVE DYSKINESIA//AKATHISIA//VACUOUS CHEWING MOVEMENTS 4715
23891 1                   DRUG INDUCED PARKINSONISM//DOTARIZINE//DOPAMINE RECEPTOR BLOCKING AGENTS 331

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 DRUG INDUCED PARKINSONISM authKW 1506733 11% 47% 35
2 DOTARIZINE authKW 1312014 5% 89% 16
3 DOPAMINE RECEPTOR BLOCKING AGENTS authKW 369005 1% 100% 4
4 LOMERIZINE authKW 355816 3% 43% 9
5 CINNARIZINE authKW 328269 7% 16% 22
6 FLUNARIZINE authKW 271126 8% 11% 27
7 FLUNARIZINE DIHYDROCHLORIDE authKW 207564 1% 75% 3
8 KB 2796 authKW 207564 1% 75% 3
9 DIPHENYLPIPERAZINE DERIVATIVES authKW 184503 1% 100% 2
10 PARKINSONS DISEASE CHEMICALLY INDUCED authKW 184503 1% 100% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Clinical Neurology 1768 32% 0% 107
2 Pharmacology & Pharmacy 1649 42% 0% 138
3 Psychiatry 142 8% 0% 28
4 Chemistry, Medicinal 107 6% 0% 20
5 Neurosciences 75 11% 0% 37
6 Chemistry, Analytical 67 8% 0% 25
7 Geriatrics & Gerontology 53 2% 0% 8
8 Medicine, General & Internal 48 7% 0% 24
9 Medical Ethics 28 1% 0% 2
10 Chemistry, Multidisciplinary 9 7% 0% 22

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 UNIDAD DOCENTE TOXICOL MED LEGAL 184503 1% 100% 2
2 AO PAVIA 92251 0% 100% 1
3 BERATUNGSZENTRUM ALSTERDORF 92251 0% 100% 1
4 CANCER EPIGENET 92251 0% 100% 1
5 CENT DRUGS FOOD ANAL 92251 0% 100% 1
6 CLIN MALATIAS SISTEMA NERVIOS 92251 0% 100% 1
7 CNRSFRE 2109 MEDCPCET PHARMACOL CLIN 92251 0% 100% 1
8 DIAGNOST NEUROL 92251 0% 100% 1
9 EQUIPE PHARMACOEPIDEMIOLINSERMU 1027 92251 0% 100% 1
10 EXTR IRAMIDAL DIS 92251 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MOVEMENT DISORDERS 5647 6% 0% 20
2 CLINICAL NEUROPHARMACOLOGY 4651 3% 0% 11
3 ETHIK IN DER MEDIZIN 2024 1% 1% 2
4 PARKINSONISM & RELATED DISORDERS 1879 2% 0% 7
5 DISSOLUTION TECHNOLOGIES 1796 1% 1% 2
6 THERAPIE 1298 2% 0% 6
7 JOURNAL OF PARKINSONS DISEASE 972 1% 1% 2
8 METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY 877 2% 0% 5
9 REVISTA DE NEUROLOGIA 815 2% 0% 7
10 JOURNAL OF CLINICAL NEUROLOGY 811 1% 0% 2

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 DRUG INDUCED PARKINSONISM 1506733 11% 47% 35 Search DRUG+INDUCED+PARKINSONISM Search DRUG+INDUCED+PARKINSONISM
2 DOTARIZINE 1312014 5% 89% 16 Search DOTARIZINE Search DOTARIZINE
3 DOPAMINE RECEPTOR BLOCKING AGENTS 369005 1% 100% 4 Search DOPAMINE+RECEPTOR+BLOCKING+AGENTS Search DOPAMINE+RECEPTOR+BLOCKING+AGENTS
4 LOMERIZINE 355816 3% 43% 9 Search LOMERIZINE Search LOMERIZINE
5 CINNARIZINE 328269 7% 16% 22 Search CINNARIZINE Search CINNARIZINE
6 FLUNARIZINE 271126 8% 11% 27 Search FLUNARIZINE Search FLUNARIZINE
7 FLUNARIZINE DIHYDROCHLORIDE 207564 1% 75% 3 Search FLUNARIZINE+DIHYDROCHLORIDE Search FLUNARIZINE+DIHYDROCHLORIDE
8 KB 2796 207564 1% 75% 3 Search KB+2796 Search KB+2796
9 DIPHENYLPIPERAZINE DERIVATIVES 184503 1% 100% 2 Search DIPHENYLPIPERAZINE+DERIVATIVES Search DIPHENYLPIPERAZINE+DERIVATIVES
10 PARKINSONS DISEASE CHEMICALLY INDUCED 184503 1% 100% 2 Search PARKINSONS+DISEASE+CHEMICALLY+INDUCED Search PARKINSONS+DISEASE+CHEMICALLY+INDUCED

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 LOPEZ-SENDON, J , MENA, MA , DE YEBENES, JG , (2013) DRUG-INDUCED PARKINSONISM.EXPERT OPINION ON DRUG SAFETY. VOL. 12. ISSUE 4. P. 487-496 36 42% 9
2 LIN, HL , LIN, HC , TSENG, YF , CHEN, SC , HSU, CY , (2017) RISK OF PARKINSONISM INDUCED BY FLUNARIZINE OR CINNARIZINE: A POPULATION-BASED STUDY.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 73. ISSUE 3. P. 365 -371 19 68% 0
3 BRIGO, F , ERRO, R , MARANGI, A , BHATIA, K , TINAZZI, M , (2014) DIFFERENTIATING DRUG-INDUCED PARKINSONISM FROM PARKINSON'S DISEASE: AN UPDATE ON NON-MOTOR SYMPTOMS AND INVESTIGATIONS.PARKINSONISM & RELATED DISORDERS. VOL. 20. ISSUE 8. P. 808 -814 20 57% 11
4 MENA, MA , DE YEBENEST, JG , (2006) DRUG-INDUCED PARKINSONISM.EXPERT OPINION ON DRUG SAFETY. VOL. 5. ISSUE 6. P. 759-771 34 38% 37
5 LOPEZ-SENDON, JL , MENA, MA , DE YEBENES, JG , (2012) DRUG-INDUCED PARKINSONISM IN THE ELDERLY INCIDENCE, MANAGEMENT AND PREVENTION.DRUGS & AGING. VOL. 29. ISSUE 2. P. 105 -118 30 35% 18
6 EL-SHERBINY, DT , EID, MI , EL-WASSEEF, DR , AL-ASHAN, RM , BELAL, F , (2005) ANALYSIS OF FLUNARIZINE IN THE PRESENCE OF SOME OF ITS DEGRADATION PRODUCTS USING MICELLAR LIQUID CHROMATOGRAPHY (MLC) OR MICROEMULSION LIQUID CHROMATOGRAPHY (MELC) - APPLICATION TO DOSAGE FORMS.JOURNAL OF SEPARATION SCIENCE. VOL. 28. ISSUE 2. P. 197-202 15 83% 26
7 ERRO, R , BHATIA, KP , TINAZZI, M , (2015) PARKINSONISM FOLLOWING NEUROLEPTIC EXPOSURE: A DOUBLE-HIT HYPOTHESIS?.MOVEMENT DISORDERS. VOL. 30. ISSUE 6. P. 780 -785 20 39% 3
8 LIM, TT , AHMED, A , ITIN, I , GOSTKOWSKI, M , RUDOLPH, J , COOPER, S , FERNANDEZ, HH , (2013) IS 6 MONTHS OF NEUROLEPTIC WITHDRAWAL SUFFICIENT TO DISTINGUISH DRUG-INDUCED PARKINSONISM FROM PARKINSON'S DISEASE?.INTERNATIONAL JOURNAL OF NEUROSCIENCE. VOL. 123. ISSUE 3. P. 170 -174 12 63% 1
9 ROMERO, JO , PADILLO, AA , (2013) DIAGNOSTIC ACCURACY OF I-123-FP-CIT SPECT IN DIAGNOSING DRUG-INDUCED PARKINSONISM: A PROSPECTIVE STUDY.NEUROLOGIA. VOL. 28. ISSUE 5. P. 276-282 14 48% 3
10 HONG, JY , SUNWOO, MK , OH, JS , KIM, JS , SOHN, YH , LEE, PH , (2016) PERSISTENT DRUG-INDUCED PARKINSONISM IN PATIENTS WITH NORMAL DOPAMINE TRANSPORTER IMAGING.PLOS ONE. VOL. 11. ISSUE 6. P. - 15 43% 0

Classes with closest relation at Level 1


Rank Class id link
1 14308 MIGRAINE PROPHYLAXIS//MIGRAINE PREVENTION//FLUNARIZINE
2 2926 TARDIVE DYSKINESIA//AKATHISIA//TARDIVE DYSTONIA
3 8489 I 123 FP CIT//VASCULAR PARKINSONISM//DOPAMINE TRANSPORTER
4 17072 VISUAL HALLUCINATIONS//HALLUCINATIONS//PARKINSONS DISEASE PSYCHOSIS
5 10889 LUBELUZOLE//NIMODIPINE//LEVEMOPAMIL
6 4492 DIHYDROPYRIDINE//SR 33557//BAY K 8644
7 16431 LY 300164//FLUNARIZINE//EXPTL EPILEPSIEFOR
8 4921 PARKINSONS DISEASE//MANEB//MOL CELLULAR TOXICOL HUMAN PLICAT
9 31820 ALVERINE//THERAPIE//ASSOC FRANCAISE REGIONAUX PHARMACOVIGILANCE
10 33665 AMENORRHEA BROMOCRIPTINE//ANTIREPRODUCTION//GALACTORRHEA HYPERPROLACTINEMIA PROLACTIN

Go to start page